BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34702045)

  • 1. Clinical values of two estrogen receptor signaling targeted lncRNAs in invasive ductal breast carcinoma.
    Ilbeigi S; Naeimzadeh Y; Davoodabadi Farahani M; Rafi Monjezi M; Dastsooz H; Daraei A; Farahani F; Dastgheib A; Mansoori Y; Tabei SMB
    Klin Onkol; 2021; 34(5):382-391. PubMed ID: 34702045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer.
    Ropri AS; DeVaux RS; Eng J; Chittur SV; Herschkowitz JI
    Breast Cancer Res; 2021 Oct; 23(1):101. PubMed ID: 34717732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of the transcription factor, FoxD3, is associated with lymph node metastases in invasive ductal carcinomas of the breast.
    Zhao H; Chen D; Wang J; Yin Y; Gao Q; Zhang Y
    Int J Clin Exp Pathol; 2014; 7(2):670-6. PubMed ID: 24551288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression analysis of novel long non-coding RNAs for invasive ductal and invasive lobular breast carcinoma cases.
    Aktan Ç; Küçükaslan AŞ; Türk BA; Yildirim I
    Pathol Res Pract; 2023 Apr; 244():154391. PubMed ID: 36868097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis of long non-coding ATB and its putative target in breast cancer.
    Nikpayam E; Soudyab M; Tasharrofi B; Sarrafzadeh S; Iranpour M; Geranpayeh L; Mirfakhraie R; Gharesouran J; Ghafouri-Fard S
    Breast Dis; 2017; 37(1):11-20. PubMed ID: 28598827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
    Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive cribriform carcinoma in a Chinese population: comparison with low-grade invasive ductal carcinoma-not otherwise specified.
    Zhang W; Zhang T; Lin Z; Zhang X; Liu F; Wang Y; Liu H; Yang Y; Niu Y
    Int J Clin Exp Pathol; 2013; 6(3):445-57. PubMed ID: 23412348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome sequencing profiles reveal lncRNAs may involve in breast cancer (ER/PR positive type) by interaction with RAS associated genes.
    Jia Y; Shi L; Yun F; Liu X; Chen Y; Wang M; Chen C; Ren Y; Bao Y; Wang L
    Pathol Res Pract; 2019 Jun; 215(6):152405. PubMed ID: 30981459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma.
    Pula B; Olbromski M; Wojnar A; Gomulkiewicz A; Witkiewicz W; Ugorski M; Dziegiel P; Podhorska-Okolow M
    Cell Oncol (Dordr); 2013 Dec; 36(6):469-83. PubMed ID: 24065215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M; Xu SP; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of DDR1 and DVL1 in invasive ductal and lobular breast carcinoma does not correlate with histological type, grade and hormone receptor status.
    Ameli F; Rose IM; Masir N
    Asian Pac J Cancer Prev; 2015; 16(6):2385-90. PubMed ID: 25824769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: a Chinese population-based study.
    Xu N; Chen F; Wang F; Lu X; Wang X; Lv M; Lu C
    Tumour Biol; 2015 Sep; 36(10):7659-65. PubMed ID: 25929808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
    Truin W; Roumen RMH; Siesling S; van de Vijver KK; Tjan-Heijnen VCG; Voogd AC
    Breast Cancer Res Treat; 2017 Jul; 164(1):133-138. PubMed ID: 28365833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High snail expression predicts a poor prognosis in breast invasive ductal carcinoma patients with HER2/EGFR-positive subtypes.
    Chang HY; Tseng YK; Chen YC; Shu CW; Lin MI; Liou HH; Fu TY; Lin YC; Ger LP; Yeh MH; Liu PF
    Surg Oncol; 2018 Jun; 27(2):314-320. PubMed ID: 29937187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
    Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
    Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.
    Hartog H; Horlings HM; van der Vegt B; Kreike B; Ajouaou A; van de Vijver MJ; Marike Boezen H; de Bock GH; van der Graaf WT; Wesseling J
    Breast Cancer Res Treat; 2011 Oct; 129(3):725-36. PubMed ID: 21107683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and significance of Twist, estrogen receptor, and E-cadherin in human breast cancer cells and tissues.
    Tan R; Wang L; Song J; Li J; He T
    J Cancer Res Ther; 2017; 13(4):707-714. PubMed ID: 28901319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.